COVID-19 Updates: Are things getting brighter?

Tap to continue exploring

India’s daily COVID-19 tally remains static

On 12th August, India recorded 40,120 new COVID-19 infections taking the country’s tally to over 3.21 crore. With 585 new fatalities, the country’s total death toll now exceeds 4.3 lakh. Currently, India has an active caseload of 3.85 lakh.

More than 50 crore vaccine doses administered across India

As of 13th August, India has administered 52,86,95,223 doses of the COVID-19 vaccines to its adult population. So far, 41,19,47,658 people have received the first dose of the COVID-19 vaccine. On the other hand, 11,67,47,565 people have been administered the second dose.

Covaxin may get WHO nod by end of August

Covaxin will likely get emergency approval from the World Health Organization (WHO) by the end of August. Currently, six COVID-19 vaccines have the WHO’s emergency approval. According to WHO’s Chief Scientist Soumya Swaminathan, Covaxin’s overall efficacy is quite high and its safety profile meets the global health body’s benchmarks.

ICMR study says combining Covishield and Covaxin may offer better protection

According to an ICMR study, mixing Covishield and Covaxin doses triggers a better immune response when compared to two doses of the same vaccine. The study was conducted on 18 people who had inadvertently received the two vaccines. More research is needed to establish this.

Study on mixing Covaxin, Covishield vaccines gets DCGI approval

Drugs Controller General of India (DCGI) has given approval for a study on mixing Covishield and Covaxin. The study will be conducted by Vellore's Christian Medical College. It will be different from the one by the ICMR, which found that mixing the two COVID-19 vaccines elicited a better immune response.

J&J single-dose COVID-19 vaccine gets emergency approval in India

India has recently granted emergency approval to Johnson & Johnson’s single-dose COVID-19 vaccine. The company had reportedly applied for emergency approval for its jab a day before and was granted the nod the same day by the Drugs Controller General of India.

Zydus Cadila COVID-19 vaccine may get emergency approval this week

Zydus Cadila may get emergency approval for its COVID-19 vaccine from the Drug Controller General of India (DCGI) very soon. The company had applied for emergency approval for the ZyCoV-D vaccine on July 1. Once approved, it would be India’s first COVID-19 vaccine for the 12-18 years age group.

Foreigners can now register for COVID-19 vaccination in India via CoWIN

Foreign nationals residing in India are now eligible for COVID-19 vaccination. Foreign nationals will need to register for COVID-19 vaccination through the CoWIN portal. They will have to use their passport for the purpose of registration.

Sputnik light may be rolled out in India in September

The Sputnik Light vaccine, developed by Russia’s Gamaleya Institute, will reportedly be rolled out in India in September. Panacea Biotec, which has partnered with the Russian Direct Investment Fund (RDIF), has submitted the dossier seeking emergency approval from the Drugs Controller General of India (DCGI).

SII applies for emergency approval of Covovax vaccine

Serum Institute of India (SII) has applied for emergency approval of Covovax, US-based Novavax's COVID-19 vaccine. The vaccine, also known as NVX-CoV2373, has an overall efficacy rate of 89.7 percent. Last year, Novavax had signed an agreement with SII for mass-scale production of vaccines for developing and low-income countries.

Want to know more about the Coronavirus?

Sign up for Apollo 24|7's health blog and never miss an update.

www.apollo247.com